Epstein-Barr virus immunossuppression of innate immunity mediated by phagocytes (Q36424417)

14 August 2017

1 reference

title

Epstein-Barr virus immunossuppression of innate immunity mediated by phagocytes (English)

1 reference

14 August 2017

0 references

Martin Savard

1

1 reference

PubMed ID

16545476

14 August 2017

Jean Gosselin

series ordinal

2

1 reference

14 August 2017

20 March 2006

1 reference

14 August 2017

1 reference

14 August 2017

119

1 reference

14 August 2017

2

1 reference

14 August 2017

134-145

1 reference

Interleukin 1 receptor antagonist. A new member of the interleukin 1 family

14 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

The PKC targeting protein RACK1 interacts with the Epstein-Barr virus activator protein BZLF1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Temporal activation of NF-kappaB regulates an interferon-independent innate antiviral response against cytoplasmic RNA viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

The immune response to Epstein-Barr virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

The production of cytokines by polymorphonuclear neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Assembly of the isomerized TFIIA--TFIID--TATA ternary complex is necessary and sufficient for gene activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

The leukocyte response during viral respiratory illness in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Infectious Mononucleosis and Agranulocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Release of anti-HIV mediators after administration of leukotriene B4 to humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Prostaglandins and leukotrienes: advances in eicosanoid biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Augmentation of human natural cytotoxic cell activity by leukotriene B4 mediated by enhanced effector-target cell binding and increased lytic efficiency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Leukotriene B4 protects latently infected mice against murine cytomegalovirus reactivation following allogeneic transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Infection of peripheral blood mononuclear cells by herpes simplex and Epstein-Barr viruses. Differential induction of interleukin 6 and tumor necrosis factor-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Inhibition of tumor necrosis factor-α transcription by Epstein-Barr virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Epstein-Barr virus primes human polymorphonuclear leucocytes for the biosynthesis of leukotriene B4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

The viral protein A238L inhibits cyclooxygenase-2 expression through a nuclear factor of activated T cell-dependent transactivation pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Capacity of Epstein-Barr virus to infect monocytes and inhibit their development into dendritic cells is affected by the cell type supporting virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Profound granulocytopenia associated with infectious mononucleosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Interferon regulatory factor 7 is negatively regulated by the Epstein-Barr virus immediate-early gene, BZLF-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Interleukin 6 and its receptor: ten years later

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Oral prostaglandin (PGE2) therapy for chronic viral hepatitis B and C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Inhibition of macrophage inflammatory protein-1 alpha production by Epstein-Barr virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Effect of heptitis C virus core protein on cellular gene expression: specific inhibition of cyclooxygenase 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Effect of tumor necrosis factor alpha on mitogen-activated human B cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

HIV-1 infection of monocyte-derived macrophages reduces Fc and complement receptor expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Protein kinase C is regulated in vivo by three functionally distinct phosphorylations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

A class of activation domains interacts directly with TFIIA and stimulates TFIIA-TFIID-promoter complex assembly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Roles for beta II-protein kinase C and RACK1 in positive and negative signaling for superoxide anion generation in differentiated HL60 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Epstein-Barr virus inhibits the development of dendritic cells by promoting apoptosis of their monocyte precursors in the presence of granulocyte macrophage-colony-stimulating factor and interleukin-4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

The Zta trans-activator protein stabilizes TFIID association with promoter DNA by direct protein-protein interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Requirement for transcription factor IIA (TFIIA)-TFIID recruitment by an activator depends on promoter structure and template competition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Serum Levels of Lymphokines and Soluble Cellular Receptors in Primary Epstein-Barr Virus Infection and in Patients with Chronic Fatigue Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Monocyte chemotactic proteins MCP-1, MCP-2, and MCP-3 are major attractants for human CD4+ and CD8+ T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Epstein-Barr virus-recent advances

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

A novel function for the Epstein-Barr virus transcription factor EB1/Zta: induction of transcription of the hIL-10 gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Differential cytokine regulation by eicosanoids in T cells primed by contact sensitisation with TNP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

The extended protein kinase C superfamily

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Antiviral effects of recombinant tumour necrosis factor in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Identification of intracellular receptor proteins for activated protein kinase C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Epstein-Barr virus immediate-early protein BZLF1 inhibits tumor necrosis factor alpha-induced signaling and apoptosis by downregulating tumor necrosis factor receptor 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Inhibition of IFN-gamma signaling by an Epstein-Barr virus immediate-early protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Infectious mononucleosis. Death due to agranulocytosis and pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Mediation of mouse natural cytotoxic activity by tumour necrosis factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Leukotrienes: underappreciated mediators of innate immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Epstein-Barr virus DNA sequences in precursor monocyte-macrophage cell lines established from the bone marrow of children with maturation defects of haematopoiesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Epstein-Barr virus induces GM-CSF synthesis by monocytes: effect on EBV-induced IL-1 and IL-1 receptor antagonist production in neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Eicosanoids: lipid mediators of inflammation in transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Common and idiosyncratic patterns of cytokine gene expression by Epstein-Barr virus transformed human B cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Role of c-myc regulation in Zta-mediated induction of the cyclin-dependent kinase inhibitors p21 and p27 and cell growth arrest.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Leukotriene B4 augments human natural cytotoxic cell activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Production of inflammatory cytokines by Epstein-Barr virus (EBV)-infected lymphoblastoid cell lines spontaneously originated from the peripheral blood of patients with human immunodeficiency virus (HIV) infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Infection of primary human monocytes by Epstein-Barr virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

EBV suppresses prostaglandin E2 biosynthesis in human monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Chemokines, leukocyte trafficking, and inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Herpesvirus DNA (Epstein-Barr virus, herpes simplex virus, cytomegalovirus) in circulating monocytes of patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Antineutrophil antibodies in infectious mononucleosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Interleukin-18, interferon-gamma, IP-10, and Mig expression in Epstein-Barr virus-induced infectious mononucleosis and posttransplant lymphoproliferative disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Expression of latent and replicative-infection genes of Epstein-Barr virus in macrophage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

bZIP proteins of human gammaherpesviruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Epstein-Barr virus entry into cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Direct and indirect regulation of cytokine and cell cycle proteins by EBNA-2 during Epstein-Barr virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Cellular Events in Zoster Vesicles: Relation to Clinical Course and Immune Parameters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Virologic, immunologic, and clinical observations on a patient during the incubation, acute, and convalescent phases of infectious mononucleosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

T-cell chemotactic activity of cytokine LD78: a comparative study with interleukin-8, a chemotactic factor for the T-cell CD45RA+ phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Impaired protein kinase C activation/translocation in Epstein-Barr virus-infected monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1 alpha and MIP-1 beta on human monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Phagocytosis of microbes: complexity in action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Phagocytosis of herpes simplex virus by human granulocytes and monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Interleukin 1 alpha acts as an autocrine growth factor for RPMI 1788, an Epstein-Barr virus-transformed human B cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Cytokine production in response to Epstein-Barr virus infection of peripheral blood mononuclear cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Serum cytokine levels in infectious mononucleosis at diagnosis and convalescence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

CCAAT/enhancer binding protein alpha interacts with ZTA and mediates ZTA-induced p21(CIP-1) accumulation and G(1) cell cycle arrest during the Epstein-Barr virus lytic cycle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Acute agranulocytosis following infectious mononucleosis. Report of a case.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

Identification of cellular target genes of the Epstein-Barr virus transactivator Zta: activation of transforming growth factor beta igh3 (TGF-beta igh3) and TGF-beta 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

7 January 2021

Epstein-Barr virus BHRF1 protein protects intestine 407 epithelial cells from apoptosis induced by tumor necrosis factor alpha and anti-Fas antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

7 January 2021

Functional changes in murine macrophages infected with cytomegalovirus relate to H-2-determined sensitivity to infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

7 January 2021

The extracellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DR beta chain and inhibits antigen presentation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.02.008

7 January 2021

10.1016/J.VIRUSRES.2006.02.008

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16545476